OTC Pharmaceuticals - Ivory Coast

  • Ivory Coast
  • Revenue in the OTC Pharmaceuticals market amounts to US$270.20m in 2024. The market is expected to grow annually by 11.21% (CAGR 2024-2029).
  • The market's largest segment is the segment Vitamins & Minerals with a market volume of US$83.30m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$9.13 are generated in 2024.
  • In the OTC Pharmaceuticals market, 1.5% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Ivory Coast is experiencing significant growth and development.

Customer preferences:
Customers in Ivory Coast have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including the convenience and accessibility of these products. OTC medications do not require a prescription, allowing consumers to easily purchase them from pharmacies and retail outlets. Additionally, OTC medications are often more affordable than prescription drugs, making them a popular choice for individuals seeking cost-effective healthcare solutions.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in Ivory Coast is the increasing demand for self-medication. As consumers become more health-conscious and proactive in managing their own health, they are turning to OTC medications for common ailments and minor health issues. This trend is driven by the availability of a wide range of OTC products, including pain relievers, cough and cold medicines, and digestive aids. The convenience of self-medication allows individuals to address their health concerns without the need for a doctor's visit, saving time and money. Another trend in the market is the growing popularity of herbal and natural OTC remedies. Traditional medicine has a long history in Ivory Coast, and many consumers prefer natural remedies for their perceived safety and effectiveness. This has led to an increase in the availability and sales of herbal OTC products, such as herbal teas, supplements, and topical treatments. The demand for these products is driven by the belief that natural remedies have fewer side effects and are better aligned with the body's natural healing processes.

Local special circumstances:
Ivory Coast has a rapidly growing population, which contributes to the increasing demand for OTC pharmaceuticals. As the population expands, so does the need for accessible healthcare solutions. OTC medications provide a convenient and affordable option for individuals to address their healthcare needs without the need for a doctor's visit. Additionally, the country's improving healthcare infrastructure, including the expansion of pharmacies and retail outlets, has made OTC products more readily available to consumers.

Underlying macroeconomic factors:
Several macroeconomic factors are driving the growth of the OTC Pharmaceuticals market in Ivory Coast. The country has experienced steady economic growth in recent years, leading to an increase in disposable income and consumer spending. This has allowed individuals to allocate more of their budget towards healthcare products, including OTC medications. Furthermore, the government's efforts to improve healthcare access and affordability have also contributed to the growth of the OTC Pharmaceuticals market. These initiatives include the expansion of health insurance coverage and the implementation of policies to promote the use of generic drugs, which are often available as OTC products. In conclusion, the OTC Pharmaceuticals market in Ivory Coast is developing rapidly due to customer preferences for convenient and affordable healthcare solutions. The increasing demand for self-medication and natural remedies, coupled with the country's growing population and improving healthcare infrastructure, are driving the growth of the market. Additionally, underlying macroeconomic factors such as economic growth and government initiatives to improve healthcare access and affordability are also contributing to the market's development.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)